On the basis of very encouraging results in melanoma patients, inhibitors of the programmed cell death protein 1/programmed cell death-ligand 1(PD1/PD-L1) pathway were also tested in HNSCC patients. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.